Bedrocan shows pharmaceutical API at CPhI 2021

Last week world’s largest pharmaceutical API & raw materials fair: CPhI Worldwide in Milan, Italy. Bedrocan was, of course, present this year again. Our team met a lot of interesting parties during the event who were curious about our standardised medicinal cannabis API. The team had a very fruitful event and spread our message on the importance of pharmaceutical quality standards for medicinal cannabis products.

Varun Arora represented our organisation and our cannabis products together with Key Account Manager Karolina Ostapenko. In addition, our Director of Product Development & Compliance Naiem Hakiemie, our Manager Legal Affairs Robert Rademaker and our Corporate Strategy Analyst Andrew Kraszewski strengthened the team.

Promoting our products

The last time Bedrocan participated in CPhI in 2019, we focused mainly on presenting our five varieties of standardised cannabis as an API. This time, Bedrocan could also introduce the trichome powder and placebo product forms. Many pharmaceutical companies showed interest in these products. Although there is no production line for these products yet, this interest certainly encourages Bedrocan to produce them on a larger scale in the future. Especially for companies from countries in which the import of cannabis flos is not allowed, having our products in a different form that can be used as raw material would be very valuable. The placebo also called the attention of those parties involved in clinical trials, as currently, there is no placebo for medicinal cannabis in the form of flos/granulate.

Additionally, Bedrocan team also promoted our unique cultivation techniques and excellent quality management system, which could also be applied to the production of other medicinal plant products.

Next year, we will be present again in CPhI Frankfurt and hope to have another successful event.